Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components

BACKGROUND: The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced glycation end products accumulation, is associated with cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: van Waateringe, Robert P., Slagter, Sandra N., van Beek, Andre P., van der Klauw, Melanie M., van Vliet-Ostaptchouk, Jana V., Graaff, Reindert, Paterson, Andrew D., Lutgers, Helen L., Wolffenbuttel, Bruce H. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450154/
https://www.ncbi.nlm.nih.gov/pubmed/28572855
http://dx.doi.org/10.1186/s13098-017-0241-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450154/
https://www.ncbi.nlm.nih.gov/pubmed/28572855
http://dx.doi.org/10.1186/s13098-017-0241-1

Ejemplares similares